�ber neue starkwirkende Analgetika und ihre klinische Erprobung
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to vandeputte et al. [7], isotonitazene produces the active metabolite N-desethyl isotonitazene, which is more potent than its parent compound [20].”
From Nitazenes: review of comparative pharmacology and antagonist action (2025) · cites this paper as [7]
Citations
Cites
Handbuch der Experimentellen Pharmakologie
(1939) · Springer eBooks · doi:10.1007/978-3-642-90793-7 · Cited by 966
Woolcock, W. J. U. (1924) · Journal of the Society of Chemical Industry · doi:10.1002/jctb.5000434102 · Cited by 881
Dolantin, ein neuartiges Spasmolytikum und Analgetikum
Eisleb, O., & Schaumann, O. (1939) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1120563 · Cited by 136
Lasagna, L. C. (1954) · JAMA · doi:10.1001/jama.1954.02950030022008 · Cited by 118
Courvoisier, S., Fournel, J., DUCROT, R., Kolsky, M., & Koetschet, P. (1953) · PubMed · Cited by 118
Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. J. (1957) · Cellular and Molecular Life Sciences · doi:10.1007/bf02161116 · Cited by 103
Über eine neue Klasse von spasmolytisch und analgetisch wirkenden Verbindungen, I
Bockmühl, M., & Ehrhart, G. (1949) · Justus Liebig s Annalen der Chemie · doi:10.1002/jlac.19495610107 · Cited by 100
A COMPARISON OF HEAT AND PRESSURE ANALGESIOMETRIC METHODS IN RATS
Green, A. F., Young, P. A., & GODFREY, W. A. A. B. >. I. (1951) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1951.tb00668.x · Cited by 99
Analgesics and their Antagonists: Some Steric and Chemical Considerations
Beckett, A. H. (1956) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1956.tb12215.x · Cited by 75
Analgesics and their Antagonists: Some Steric and Chemical Considerations: P art
Beckett, A. H., CASY, A. F., & Harper, N. J. (1956) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1956.tb12217.x · Cited by 72
Research works printed but not linked: 17
- Eisleb, O.: Med. u. Chem.4, 213 (1942).
- Schaumann, O.: Pharmazie4, 364 (1949).
- Green, A. F.: Brit. J. Pharmacol.8, 2 (1953).
- Pohl, J.: Mercks Jber. Pharm.29, 204 (1915).
- Malorny, G.: Arzneimittel-Forsch.5, 252 (1955).
- Richterlich van Baerle, R. W. W. Byrnes: Z. inn. Med.10, 1017 (1955).
- Costa, P. J., andD. D. Bonnycastle: J. Pharmacol. u. a.113, 12 (1955).
- Flintan, P., andC. A. Keele: Brit. J. Pharmacol.9, 106 (1954).
- Flintan, P., andC. A. Keele: J. Pharmacol. exp. Ther.110, 18 (1954).
- Courvoisier, S., J. Fournel, R. Ducrot, M. Kolsky u.P. Koetschet: Arch. int. Pharmacodyn.92, 305 (1953).
- Nieschulz, O. u. a.: Arzneimittel-Forsch.4, 3?32 (1954).
- Green, A. F., andP. A. Young: Brit. J. Pharmacol.6, 572 (1951).
- Keats, A. S., andH. K. Beecher: J. Pharmacol. exp. Ther.100, 1 (1950).
- Riesser, O.: Zit. nachL. Lendle: Öff. Gesundh.-Dienst12, 372 (1950).
- Himmelsbach, C. K.: J. Pharmacol. exp. Ther.75, 64 (1942).
- Kraemer, R.: Nervenarzt23, 33 (1950).
- Lendle, L.: Öff. Gesundh.-Dienst12, 380 (Fußnote) (1950).
Cited by
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141
Blanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116
Krotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89
De Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
“Despite their promising antinociceptive properties, nitazenes were never marketed, possibly due to a high risk of adverse effects (Bromig 1958; Ujváry et al. 2021).”
BackgroundMu-Opioid Receptor Selective Superagonists Produce Prolonged Respiratory Depression
Malcolm, N. J., Palkovic, B., Sprague, D. J., Calkins, M. M., Lanham, J. K., Halberstadt, A. L., Stucke, A. G., & McCorvy, J. D. (2023) · iScience · doi:10.1016/j.isci.2023.107121 · Cited by 53
“For example, one-fifth of the patients who received metonitazene in a clinical trial showed evidence of cyanosis and one participant lost consciousness and had to be revived using nalorphine.(53) This study provides further evidence of the potential of these types of compounds to produce respiratory depression.”
BackgroundDe Luca, M. A., Tocco, G., Mostallino, R., Laus, A., Caria, F., Musa, A., Pintori, N., Ucha, M., Poza, C., Ambrosio, E., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109263 · Cited by 48
Vandeputte, M. M., Verougstraete, N., Walther, D., Glatfelter, G. C., Malfliet, J., Baumann, M. H., Verstraete, A. G., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03294-2 · Cited by 44
“While promising in terms of their antinociceptive effects, none of these substances were ever further developed into medicines, likely due to a high risk of adverse events (Bromig 1958; EMCDDA 2020; Ujváry et al. 2021).”
BackgroundVandeputte, M. M., Tsai, M.-H. M., Chen, L., Glatfelter, G. C., Walther, D., Stove, C. P., Shi, L., & Baumann, M. H. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109939 · Cited by 39
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Vandeputte, M. M., Glatfelter, G. C., Walther, D., Layle, N. K., St. Germaine, D. M., Ujváry, I., Iula, D. M., Baumann, M. H., & Stove, C. P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107503 · Cited by 35
Nitazenes: review of comparative pharmacology and antagonist action
Stangeland, M., Dale, O., & Skulberg, A. K. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2504133 · Cited by 34
“…of lower relative analgesic potency in humans than that under experimental conditions were found in a clinical study of postoperative pain by Bromig [8]. while the in vitro antinociceptive potency of metonitazene is 100 times greater than that of morphine, it is only 10 times greater in humans.”
InfluentialSiczek, M., Zawadzki, M., Siczek, M., Chłopaś‐Konowałek, A., & Szpot, P. (2020) · Forensic Toxicology · doi:10.1007/s11419-020-00552-9 · Cited by 28
The emergence of nitazenes: a new chapter in the synthetic opioid crisis
Caprari, C., Ferri, E., Rossetti, P., Gregori, A., Citti, C., & Cannazza, G. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04102-3 · Cited by 19
“Metonitazene, alongside clonitazene and etonitazene, was one of the few 2-benzylbenzimidazole compounds studied in clinical trials as an analgesic in postoperative or trauma patients during the late 1950s (Bromig 1958).”
2 The Testing and Development of Analgesic Drugs
Beckett, A. H., & CASY, A. F. (1962) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70433-8 · Cited by 17
Dimić, D. (2025) · Chemosensors · doi:10.3390/chemosensors13120426 · Cited by 18
CASY, A. F., & WRIGHT, J. (1966) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1966.tb07782.x · Cited by 12
The Structure of Narcotic Analgesic Drugs
CASY, A. F. (1971) · Springer eBooks · doi:10.1007/978-1-4684-1869-9_1 · Cited by 9
Kreutzberger, A., & Burgwitz, K. (1979) · Archiv der Pharmazie · doi:10.1002/ardp.19793121014 · Cited by 8
Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids
Nielsen, S., Silva, J. P., Jones, J. D., Krotulski, A., Poovendran, D., Muzangizi, D., Forte, G., White, J., & Comer, S. D. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70040 · Cited by 6
Truver, M. T., Roman, M., Gomonit, M. M., Gréen, H., Kronstrand, R., & Persson, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04407-x · Cited by 4
“The “first generation” of 2-benzylbenzimidazoles that appeared between 2019 to 2022 largely reflected the structural motifs from historical CIBA studies (Gross and Turrian 1957 ; Bromig 1958 ; Hunger et al. 1960a , b ).”
Barra, B. F. C., Pereira, J. R. P., Ferreira, D. R., Oeri, H. E., Martins, D. J. M., Almeida, R. M., Oatley, G., Neng, N. R., Gaspar, H., & Quintas, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-35256-4 · Cited by 1
Everything you need to know about nitazenes
(2024) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2024.1.217916 · Cited by 1
Kunz, W. (1966) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7059-7_7
Miscellaneous Groups of Analgesics
CASY, A. F., & Parfitt, R. T. (1986) · Springer eBooks · doi:10.1007/978-1-4899-0585-7_11
Kunz, W. (1961) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7041-2_4
Jelin, D. F., & Venezuela, A. L. (2022) · Revista de Ensino de Ciências e Matemática · doi:10.26843/rencima.v13n2a01
Upadhyay, N., Neel, L. T., Li, E., Silte, A. A., Lyu, R., Selley, D. E., Dewey, W. L., Zhang, Y., & Pagare, P. P. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00283
“1, 2, 4, 5, 6, 9, 13, 17, 19, 21, 25, 26, 27, and 31 that demonstrated the most significant reductions in induction of Ca 2+ flux ( **** P 0.0001, compared to 10 μ M DAMGO) were studied further for their potential to modulate the effect of MOR agonists.”
InfluentialMiskulin, A., Shkolnikov, I., Sboto, J. N. S., Kielty, C., Wallace, B. B., Gill, C. G., & Hore, D. K. (2026) · Drug Testing and Analysis · doi:10.1002/dta.70135
Metadata
- Authors
- Bromig, G.
- Affiliations
- University Hospital Frankfurt (DE)
- Corresponding author
- Bromig, Georg
- Venue
- Klinische Wochenschrift
- Published
- 1958-10
- Volume
- 36
- Issue
- 20
- Pages
- 960-963
- ISSN
- 0946-2716 (ISSN-L)
- 0023-2173
- 1432-1440
- OpenAlex
- W1966804470
- Cited by
- 29
- References
- 34
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 1
- FWCI
- 1.57
- Type
- journal article
- Language
- de
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- benzimidazole derivatives, synthetic analgesics, morphine analogues, analgesic activity, clinical evaluation, adverse effects, structure-activity relationship
- MeSH terms
- Analgesics, Analgesics, Non-Narcotic, Antipyretics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.